Skip to content
★ Sign in to follow
CH

Concord Healthcare Group Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong

HK·Mcap HK$505.5MHealth Care

1 insider bought €21k of shares over the last 90 days, the latest by NG KWOK YIN, filed 25 Aug 2026.

Concord Healthcare Group Co., Ltd. - H Shares: what insiders have been doing

Every trade that managers of Concord Healthcare Group Co., Ltd. - H Shares disclose to HKEX is tracked on this page. The company sits in the Health Care sector. Between 23 October 2025 and 23 October 2026, 2 insiders published 3 filings.

Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €21k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €21k, bought by Ng Kwok Yin and made public on 25 August 2026. Those buying include 1 senior executive.

The last purchase on record was published on 25 August 2026, which is 75 days ago. The median gap between a trade and its publication by HKEX is 3 days. This delay matters because a trade only becomes useful information once it is public.

For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 3 filings here. Our records for Concord Healthcare Group Co., Ltd. - H Shares go back to 2026, with 1 purchase and no sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
€20,999
1 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Ng Kwok Yin1 buy

Since the insiders bought

  • Filed 25 Aug 2026 · 75 days ago · €21k
    +18.7%
    Entry HK$19.80 · Close at T+30 HK$23.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 26,657 of 26,897 companies
6.5
score / 100
Value
4
Quality
9
FCF yld-54%
Earn yld-53%
EV/EBITDA·
ROE-11%
Gross mgn6.9%
Net mgn-56%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.65
Analyst consensus
·
Income statement
RevenueHK$459.9M
Gross profitHK$32M7% margin
EBITDA-HK$33.4M-7% margin
Net income-HK$256.6M-29.8% margin
Valuation
P/Book0.2x
Beta-0.47
Balance sheet & cash
Market capHK$505.5M
Total debtHK$3.1B
Free Cash Flow-HK$260M
Debt / Equity160%
Profitability & ownership
ROE-10.9%
ROA-1.0%
% insiders20.4%
% institutions0.0%
Last declaration on 14 September 2026
Declarations3 total
  • ●
    DirectorExecutives
    0HKEX
    35,602,300 sharesShareXHKGHKEX:DA20260911E00557
  • ●
    DirectorExecutives
    0HKEX
    96,137,318 sharesShareXHKGHKEX:DA20260903E00558
  • ▲
    DirectorExecutives
    192,276 HKD22HKEX
    222,800 shares@ HK$0.863100.0% of flowShareXHKGHKEX:DA20260825E00001
    Canonical exit: 22 Nov 2026 (T+90)

3 of 3 declarations

About Concord Healthcare Group Co., Ltd. - H Shares

Concord Healthcare Group Co., Ltd. is a Chinese company engaged in the manufacturing and distribution of pharmaceutical products. It is listed on the Hong Kong Stock Exchange under the H Shares symbol.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations